Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
No dose adjustment needed
A common research-planning SubQ start is 50 mg (about 0.50 mL at 100 mg/mL) once weekly or three times weekly, then escalate by ~25 mg as tolerated
Impaired cerebral perfusion in multiple sclerosis: relevance of endothelial factors
A clinical study on modified growth hormone releasing factor (CJC-1295) demonstrated sustained increases in GH and IGF-1 levels following repeated dosing with a favorable safety profile, supporting the use of consistent dosing over multi-week protocols
Research Preservative: to prevent bacterial growth in vials
:max_bytes(150000):strip_icc()/VWH-GettyImages-2276706586.jpg-4e49ad1f948143ed99767b89bf0289d7.jpg)
US$ 22.23
US$ 27.37
US$ 27.19
US$ 20.09
US$ 24.63
US$ 26.40
